Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 6 studies | 23% ± 6% | |
| glutamatergic neuron | 5 studies | 46% ± 24% | |
| microglial cell | 4 studies | 19% ± 4% | |
| epithelial cell | 4 studies | 28% ± 5% | |
| neuron | 3 studies | 21% ± 7% | |
| GABAergic neuron | 3 studies | 50% ± 7% | |
| macrophage | 3 studies | 20% ± 2% | |
| astrocyte | 3 studies | 29% ± 10% | |
| oligodendrocyte | 3 studies | 24% ± 7% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 44% ± 12% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 3503.64 | 1445 / 1445 | 100% | 14.83 | 183 / 183 |
| lung | 100% | 2430.90 | 578 / 578 | 100% | 12.09 | 1155 / 1155 |
| ovary | 100% | 2045.48 | 180 / 180 | 100% | 12.10 | 430 / 430 |
| breast | 100% | 2427.29 | 459 / 459 | 100% | 14.23 | 1116 / 1118 |
| prostate | 100% | 2109.19 | 245 / 245 | 100% | 9.45 | 500 / 502 |
| thymus | 100% | 2750.99 | 653 / 653 | 100% | 13.15 | 602 / 605 |
| brain | 99% | 1613.03 | 2627 / 2642 | 100% | 11.84 | 705 / 705 |
| intestine | 100% | 2078.61 | 966 / 966 | 99% | 7.89 | 524 / 527 |
| bladder | 100% | 2134.67 | 21 / 21 | 99% | 10.45 | 501 / 504 |
| uterus | 100% | 2465.24 | 170 / 170 | 99% | 12.88 | 456 / 459 |
| stomach | 100% | 1447.71 | 358 / 359 | 99% | 8.27 | 283 / 286 |
| kidney | 100% | 1533.88 | 89 / 89 | 99% | 10.28 | 888 / 901 |
| pancreas | 99% | 837.08 | 325 / 328 | 98% | 7.85 | 175 / 178 |
| skin | 100% | 2748.21 | 1809 / 1809 | 97% | 11.54 | 457 / 472 |
| adrenal gland | 100% | 1424.88 | 258 / 258 | 95% | 7.39 | 219 / 230 |
| liver | 100% | 960.22 | 226 / 226 | 92% | 4.44 | 374 / 406 |
| adipose | 100% | 2200.60 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1897.13 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 10.58 | 29 / 29 |
| muscle | 100% | 2678.88 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2350.61 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 15.04 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 6.22 | 1 / 1 |
| heart | 99% | 2090.96 | 849 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 96% | 1725.06 | 892 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 89% | 5.63 | 71 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_1903901 | Biological process | negative regulation of viral life cycle |
| GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
| GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
| GO_0000785 | Cellular component | chromatin |
| GO_0005634 | Cellular component | nucleus |
| GO_0061630 | Molecular function | ubiquitin protein ligase activity |
| GO_0003714 | Molecular function | transcription corepressor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | ARK2N |
| Protein name | Protein ARK2N (ARKadia-like protein 1) (Arkadia (RNF111) N-terminal like PKA signaling regulator protein 2N) Chromosome 18 open reading frame 25 |
| Synonyms | ARKL1 C18orf25 |
| Description | FUNCTION: AMPK substrate important for exercise capacity and skeletal muscle function. Required for normal contraction-induced signaling. .; FUNCTION: (Microbial infection) Upon Epstein-Barr virus (EBV) infection, suppresses viral BZLF1 expression and subsequent EBV reactivation by interacting with JUN and inhibiting its transcriptional activitor activity on BZLF1 Z promoter. . |
| Accessions | ENST00000615052.5 [Q96B23-1] ENST00000587591.5 ENST00000588730.1 ENST00000615553.1 K7ER64 ENST00000619301.4 [Q96B23-2] K7EQH1 Q96B23 A0A087WVF1 |
